Fuertes, Thelma C.

HRN: 22-58-63  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/28/2025
05/04/2025
IVTT
300mg
Every 6hrs
Non Healing Wound
Waiting Final Action 
04/28/2025
MUPIROCIN 2%, 15G (TUBE)
04/29/2025
05/05/2025
TOPICAL
1g
Twice A Day
Non Healing Wound
Waiting Final Action 
05/01/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/01/2025
05/08/2025
TOPICAL
2
BiD
Non Healing Wound
Waiting Final Action 
05/05/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/05/2025
05/12/2025
IV
300 Mg
Q6hrs
Infected Wound Left Foot; DM Foot
Waiting Final Action 
05/06/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/06/2025
05/13/2025
IV
300 Mg
Q6hrs
Infected Wound Left Foot; DM Foot
Waiting Final Action 
05/07/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/07/2025
05/07/2025
IV
4.5g
Loading Dose
Infected Wound Left Foot
Waiting Final Action 
05/07/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/07/2025
05/13/2025
IV
2.25g
Q6H
Infected Wound Left Foot
Waiting Final Action 
05/11/2025
MUPIROCIN 2%, 15G (TUBE)
05/11/2025
05/18/2025
TOPICAL
As Needed
BID
Sacral Ulcer
Waiting Final Action 
05/12/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/12/2025
05/26/2025
IV
4.5
Q8
Sacral Ulcer, Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: